<DOC>
	<DOCNO>NCT03064893</DOCNO>
	<brief_summary>Breast reconstruction mastectomy show provide psychosocial benefit breast cancer patient consider integral part breast cancer treatment . In general , breast reconstruction accomplish use patient tissue implantable prosthetic device . Various acellular dermal matrix ( ADMs ) offer market cost vary widely despite similar quality . The two commonly use ADM product North America far Dermacell Alloderm . The difference two product include ) level sterility , Dermacell sterilize 10-9 Alloderm sterilize 10-6 b ) consistency thickness biologic material c ) significant different cost ( $ 2200 CAD vs $ 3600 , respectively ) . Each product show safe effective . As , clinical equipoise exist . This pragmatic trial evaluate Dermacell Alloderm head head randomize fashion , regard postoperative complication , namely infection , seroma formation ( measure drain duration output ) , loss implant , incidence revisional surgery capsular contracture .</brief_summary>
	<brief_title>The Use Alloderm Versus Dermacell Immediate Implant Based Breast Reconstruction</brief_title>
	<detailed_description />
	<criteria>Female patient Ages 2090 All patient undergo mastectomy breast cancer prophylaxis breast cancer immediate implantbased reconstruction Able provide verbal consent Patients prior chest wall irradiation reconstruct side Patients undergo immediate breast reconstruction time mastectomy Any patient contraindication immediate breast reconstruction</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>